(Q46207989)
Statements
A double-blind placebo-controlled discontinuation study of zuclopenthixol for the treatment of aggressive disruptive behaviours in adults with mental retardation - secondary parameter analyses (English)
F Hässler
T Glaser
M Beneke
A Diefenbacher
O Reis
Zuclopenthixol Disruptive Behavior Study Group